| PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 109, 314-341, 2016 | 585 | 2016 |
| Anti-cancer chalcones: Structural and molecular target perspectives DK Mahapatra, SK Bharti, V Asati European journal of medicinal chemistry 98, 69-114, 2015 | 560 | 2015 |
| Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives DK Mahapatra, V Asati, SK Bharti European journal of medicinal chemistry 92, 839-865, 2015 | 291 | 2015 |
| Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives DK Mahapatra, SK Bharti, V Asati European journal of medicinal chemistry 101, 496-524, 2015 | 236 | 2015 |
| Chalcone derivatives: anti-inflammatory potential and molecular targets perspectives DK Mahapatra, SK Bharti, V Asati Current topics in medicinal chemistry 17 (28), 3146-3169, 2017 | 182 | 2017 |
| 1, 3, 4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents S Bajaj, V Asati, J Singh, PP Roy European journal of medicinal chemistry 97, 124-141, 2015 | 167 | 2015 |
| Thiazolidine-2, 4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 87, 814-833, 2014 | 158 | 2014 |
| Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications DK Mahapatra, SK Bharti, V Asati, SK Singh European journal of medicinal chemistry 174, 142-158, 2019 | 106 | 2019 |
| PIM kinase inhibitors: Structural and pharmacological perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 172, 95-108, 2019 | 67 | 2019 |
| An updated patent review of therapeutic applications of chalcone derivatives (2014-present) D Kar Mahapatra, V Asati, SK Bharti Expert opinion on therapeutic patents 29 (5), 385-406, 2019 | 61 | 2019 |
| K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 125, 299-314, 2017 | 57 | 2017 |
| MEK inhibitors in oncology: a patent review (2015-Present) DK Mahapatra, V Asati, SK Bharti Expert Opinion on Therapeutic Patents, 2017 | 45 | 2017 |
| Design, synthesis and molecular modeling studies of novel thiazolidine-2, 4-dione derivatives as potential anti-cancer agents V Asati, SK Bharti Journal of Molecular Structure 1154, 406-417, 2018 | 38 | 2018 |
| Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches V Asati, A Anant, P Patel, K Kaur, GD Gupta European Journal of Medicinal Chemistry 225, 113781, 2021 | 34 | 2021 |
| Synthesis, characterization and antimicrobial evaluation of some 1, 3-benzothiazole-2-yl-hydrazone derivatives V Asati, NK Sahu, A Rathore, S Sahu, DV Kohli Arabian Journal of Chemistry 8 (4), 495-499, 2015 | 34 | 2015 |
| An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent S Bhattacharya, A Rathore, D Parwani, C Mallick, V Asati, S Agarwal, ... European Journal of Medicinal Chemistry 204, 112523, 2020 | 30 | 2020 |
| Virtual screening, molecular docking, and DFT studies of some thiazolidine‐2, 4‐diones as potential PIM‐1 kinase inhibitors V Asati, SS Thakur, N Upmanyu, SK Bharti ChemistrySelect 3 (1), 127-135, 2018 | 25 | 2018 |
| Triggering PIK3CA mutations in PI3K/Akt/mTOR axis: exploration of newer inhibitors and rational preventive strategies V Asati, S K Bharti, D Kar Mahapatra, V Asati, A K Budhwani Current pharmaceutical design 22 (39), 6039-6054, 2016 | 22 | 2016 |
| Current insights into the chemistry and antitubercular potential of benzimidazole and imidazole derivatives D Parwani, S Bhattacharya, A Rathore, C Mallick, V Asati, S Agarwal, ... Mini Reviews in Medicinal Chemistry 21 (5), 643-657, 2021 | 21 | 2021 |
| Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents S Bhattacharya, V Asati, M Mishra, R Das, V Kashaw, SK Kashaw Journal of Molecular Structure 1227, 129511, 2021 | 20 | 2021 |
Dr. Sanjay K. BhartiGuru Ghasidas Central University, Bilaspur在 ggu.ac.in 的电子邮件经过验证
